Sichuan Gangtong Medical Equipment Group Co., Ltd (SHE:301515)
20.21
+0.02 (0.10%)
At close: Oct 9, 2026
SHE:301515 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 767.48 | 698.35 | 672.27 | 755.11 | 146.35 | 95.2 |
Trading Asset Securities | - | - | 50.96 | - | - | - |
Cash & Short-Term Investments | 767.48 | 698.35 | 723.23 | 755.11 | 146.35 | 95.2 |
Cash Growth | 9.51% | -3.44% | -4.22% | 415.96% | 53.73% | -18.86% |
Accounts Receivable | 695.29 | 779.19 | 771.89 | 735.06 | 597.46 | 455.6 |
Other Receivables | 18.74 | 10.8 | 12.39 | 19.27 | 16.77 | 3.38 |
Receivables | 714.03 | 789.98 | 784.29 | 754.33 | 614.23 | 458.98 |
Inventory | 286.74 | 280.78 | 204.2 | 295.74 | 211.84 | 242.07 |
Prepaid Expenses | 0.2 | 0.26 | 0.2 | 0.22 | 0.13 | 0.1 |
Other Current Assets | 38.89 | 17.55 | 11.25 | 10.45 | 21.6 | 42.08 |
Total Current Assets | 1,807 | 1,787 | 1,723 | 1,816 | 994.15 | 838.43 |
Property, Plant & Equipment | 147.78 | 143.56 | 113.08 | 84.49 | 57.75 | 56.48 |
Long-Term Investments | 13.14 | 13.31 | 5.48 | 5.62 | 6.17 | 10.21 |
Other Intangible Assets | 21.61 | 22.16 | 23.17 | 24.26 | 47.25 | 48.39 |
Long-Term Accounts Receivable | 35.25 | 36.19 | 29.03 | 26.66 | 27.65 | 26.28 |
Long-Term Deferred Tax Assets | 58.4 | 55.06 | 44.67 | 36.36 | 27.09 | 19.87 |
Long-Term Deferred Charges | - | - | 1.36 | 0.38 | 0.5 | 0.7 |
Other Long-Term Assets | 6.58 | 7.3 | 7.04 | 3.1 | 2.8 | 2.96 |
Total Assets | 2,090 | 2,064 | 1,947 | 1,997 | 1,163 | 1,003 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 190.59 | 252.04 | 180.49 | 225.45 | 185.69 | 123.64 |
Accrued Expenses | 88.81 | 115.2 | 73.47 | 112.13 | 80.87 | 55.78 |
Short-Term Debt | 224.02 | 198.1 | 145.61 | 109.11 | 73.08 | 73.94 |
Current Portion of Long-Term Debt | 14.7 | 3.63 | 40.63 | - | 1.26 | - |
Current Portion of Leases | 4.06 | 3.81 | 6.93 | 5.98 | 3.6 | 3.67 |
Current Income Taxes Payable | 0.01 | 6.75 | 7.26 | 17.44 | 10.33 | 12.18 |
Current Unearned Revenue | 219.7 | 175.55 | 140.35 | 130.88 | 160.49 | 164.13 |
Other Current Liabilities | 10.7 | 12.64 | 21.35 | 27.36 | 53.37 | 54.09 |
Total Current Liabilities | 752.59 | 767.71 | 616.1 | 628.34 | 568.68 | 487.43 |
Long-Term Debt | 97.05 | 39.9 | 8.4 | - | 4.75 | - |
Long-Term Leases | 5.02 | 2.56 | 5.91 | 8.51 | 6.47 | 6.8 |
Long-Term Unearned Revenue | 12.47 | 12.85 | 13.62 | 11.95 | 12.77 | 13.32 |
Long-Term Deferred Tax Liabilities | 1.27 | 0.9 | 1.83 | 2.34 | 1.57 | 0.03 |
Other Long-Term Liabilities | 15.41 | 17.22 | 16.13 | 16.84 | 14.78 | 11.87 |
Total Liabilities | 883.81 | 841.14 | 661.99 | 667.98 | 609.02 | 519.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 100 | 100 | 100 | 100 | 75 | 75 |
Additional Paid-In Capital | 793.53 | 793.53 | 793.53 | 793.53 | 128.54 | 128.54 |
Retained Earnings | 381.48 | 399.83 | 414 | 437.05 | 353.95 | 280.15 |
Treasury Stock | -73.14 | -73.14 | -23.78 | - | - | - |
Comprehensive Income & Other | 6.64 | 4.65 | 1.25 | -1.85 | -3.16 | 0.18 |
Total Common Equity | 1,209 | 1,225 | 1,285 | 1,329 | 554.33 | 483.87 |
Minority Interest | -2.23 | -1.53 | - | - | - | - |
Shareholders' Equity | 1,206 | 1,223 | 1,285 | 1,329 | 554.33 | 483.87 |
Total Liabilities & Equity | 2,090 | 2,064 | 1,947 | 1,997 | 1,163 | 1,003 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 344.85 | 247.99 | 207.49 | 123.6 | 89.15 | 84.41 |
Net Cash (Debt) | 422.63 | 450.36 | 515.74 | 631.51 | 57.2 | 10.79 |
Net Cash Growth | -1.84% | -12.68% | -18.33% | 1004.08% | 430.06% | -82.39% |
Net Cash Per Share | 4.40 | 4.66 | 5.20 | 7.39 | 0.76 | 0.14 |
Filing Date Shares Outstanding | 96.04 | 96.04 | 96.16 | 99.24 | 75 | 75 |
Total Common Shares Outstanding | 96.04 | 96.04 | 96.16 | 100 | 75 | 75 |
Working Capital | 1,055 | 1,019 | 1,107 | 1,188 | 425.47 | 351 |
Book Value Per Share | 12.58 | 12.75 | 13.36 | 13.29 | 7.39 | 6.45 |
Tangible Book Value | 1,187 | 1,203 | 1,262 | 1,304 | 507.08 | 435.47 |
Tangible Book Value Per Share | 12.36 | 12.52 | 13.12 | 13.04 | 6.76 | 5.81 |
Buildings | 126.69 | 124.66 | 63.18 | 38.57 | 40.26 | 39.08 |
Machinery | 66.34 | 67.49 | 58.4 | 50.85 | 49.27 | 48.43 |
Construction In Progress | 5.69 | 4.56 | 34.18 | 30.01 | 4.64 | 1.15 |